原发中枢神经系统非何杰金淋巴瘤被引量：1

导出

摘要原发中枢神经系统非何杰金淋巴瘤北京医学会放射肿瘤学会北京医学会放射肿瘤学会于１９９５年１０月举行原发中枢神经系统非何杰金淋巴瘤（ＰＣＮＳＬ）的病例讨论学术活动，整理如下。１病例例１，女，６６岁。１９９４年８月ＣＴ证实左颞顶部侧脑室旁肿物，周围明显水肿...

机构地区北京医学会放射肿瘤学会

出处《中华放射肿瘤学杂志》 CSCD 1996年第3期73-73,共1页 Chinese Journal of Radiation Oncology

关键词中枢神经系统非何杰金放射肿瘤学淋巴瘤放疗反应细胞型肾上腺皮质激素立体定向照射免疫抑制剂医学会

同被引文献7

1Maleney DG, Liles TM, Czerwinski DK, et al. Phase I clinical trial using escalating sing-dose infusion of chimeric anti-CD20 monoclonal antibody(IDED-C2B8) in patients with recurrent B-cell lymphoma[J].Blood, 1994, 84(8): 2457-2466.
2Shan D, ledbetter JA, Press OW. Apoptosis of malignant human B cells by ligation of CD20 with monoclonal antibodies[J].Blood, 1998, 91 (5): 1644-1652.
3Golay J, Zaffaroni L, Vaccari T, et al. Biologic response of B-lymphoma ceils to anti-CD20 monoclonal antibody rituximab in vitro:CD55 and CD59 regulate complement-mediated ceil lysis[J].Blood, 2000, 95(12): 3900-3908.
4Ghetie MA, Bright H, Vitetta ES. Homodimers but notmonomers of Rimxan(chimeric anti-CD20) induce apoptosis in human B-lymphoma cells and synergize with a chemothera-peutic agent and an immunotoxin[J]. Blood, 2001, 97(5): 1392-1398.
5Vose JM, Link B K, GrossbardM L, et al. Phase Ⅱ study of Rit-uximab in combination with CHOP chemotherapy in patients with previously untreated, aggessive non-Hodgkin' s lymphoma [J]. J Clin Oncol, 2001, 19(2): 389-397.
6刘彤华.诊断病理学[M].北京：人民卫生出版社,1995.94-95.
7雷鹏.中枢神经系统原发性恶性淋巴瘤的研究进展(综述)[J].中华神经外科杂志,1992,8(3):225-227. 被引量：19

中华放射肿瘤学杂志

1996年第3期

内容加载中请稍等...